Kv 7 positive modulators reduce detrusor overactivity and increase bladder capacity in rats

Area of Science:

• Pharmacology
• Urology
• Neuroscience

Background:

• Overactive bladder (OAB) is a condition characterized by urinary urgency and frequency.
• Current OAB treatments have limitations, necessitating novel therapeutic strategies.
• Kv 7 channels are implicated in smooth muscle function and represent a potential drug target for OAB.

Purpose of the Study:

• To investigate the therapeutic potential of Kv 7 channel openers for overactive bladder.
• To evaluate the effects of retigabine (Kv 7 opener) and XE991 (Kv 7 blocker) on rat bladder function ex vivo and in vivo.

Main Methods:

• Organ bath studies on capsaicin-stimulated rat bladder rings.
• In vivo studies in anesthetized and conscious rats with induced bladder overactivity (acetic acid or capsaicin).
• RT-qPCR and Western blotting to analyze Kv 7 subunit expression in rat bladder tissue.

Main Results:

• Retigabine significantly reduced capsaicin-induced bladder ring contractility, an effect blocked by XE991.
• In vivo, retigabine increased bladder capacity and reduced bladder pressure in overactive rat bladders.
• Kv 7.1, Kv 7.4, and Kv 7.5 mRNA and Kv 7.4 protein were detected in rat bladder tissue.

Conclusions:

• Kv 7 channel modulators, specifically openers like retigabine, demonstrate significant efficacy in ameliorating bladder overactivity.
• The expression of Kv 7 subunits in bladder tissue supports their role in bladder function.
• Kv 7 channel openers represent a promising therapeutic avenue for treating overactive bladder.